Researchers from Ajou University Medical Center (AUMC) and Eureka Skin and Laser Clinic have confirmed the clinical benefits of the skin seeding technique (SST) in treating vitiligo in children.Vitiligo is a skin disease that appears as white spots when the pigment cells that produce melanin are los
Samsung Biologics has officially asked the latecomer Lotte Biologics to stop talent poaching amid ongoing disputes over whether three ex-Samsung employees leaked Samsung’s trade secrets to Lotte, Yonhap News reported on Thursday. Samsung Biologics has sent three packs of certified mail to Lotte Biol
GenNBio expressed its goal to lead clinical trials of xenotransplantation of pancreatic islets globally and develop new treatment options for incurable diseases.The company held a press conference on Wednesday to update its development of pig pancreatic islet transplantation. The company hopes that
SK Bioscience, the Korean vaccine maker, said its annual sales and operating profit fell drastically in 2022 due to the waning global demand for Covid-19 vaccines. According to the company's public filing on Wednesday, the company recorded sales and operating profit of 456.7 billion won and 115 bill
Micrococcus luteus-derived bacterial extracellular vesicles (MIEVs) inhibited airway inflammation in patients with neutrophilic asthma, Korean researchers said. Micrococcus luteus is a commensal bacterium commonly found in the skin, mouth, nose, and upper respiratory tract.The research team, led by
Two rare disease treatments – Nefecon Cap (budesonide) and Pegcetacoplan Inj -- have been designated as subject to the innovative global product on a fast track (GIFT).The Ministry of Food and Drug Safety said Tuesday that it designated the two drugs as Nos. 2 and 3 products subject to GIFT.GIFT is
Medytox sold some of its shares in Evolus in the United States, where it maintained the largest shareholder status, raising questions among industry watchers.Evolus is also the U.S. partner of Daewoong Pharmaceutical in marketing the latter’s botulinum toxin product Nabota.In a public filing Wednesd
Researchers at Seoul National University Bundang Hospital (SNUBH) and Samsung Medical Center (SMC) said they have become “the world’s first” to discover how normal gallbladder epithelial cells evolve from precancerous lesions to primary gallbladder or metastatic gallbladder cancer cells.The team, le
Chocolate is not a love potion. When it was difficult to check facts quickly online, people used to believe that chocolate contained chemical substances that make people feel good. However, this is not true. Chocolate contains a substance called phenylethylamine (PEA), which acts as a stimulant in h
AstraZeneca is rapidly expanding its breast cancer treatment pipelines by genetic subtype, beginning with the release of antibody-drug conjugate (ADC) developed jointly with Daiichi Sankyo.Enhertu (trastuzumab deruxetecan), AZ and Daiichi Sankyo’s ADC treatment for breast cancer, expanded its domest
Prestige Biopharma said on Thursday that it published the phase 3 multinational clinical results for its Herceptin (ingredient: trastuzumab) biosimilar, HD201(brand name: Tuznue) in the BMC Cancer journal. The company plans to seek FDA approval.HD-201 is the company’s first biosimilar with indicatio
Vivozon Pharmaceutical said on Thursday that it confirmed the safety and efficacy of its non-narcotic painkiller, Unafra (ingredient: opiranserine) in phase 3 clinical trials in Korea and would seek domestic marketing authorization this year.Opiranserine (VVZ-149) is an investigational non-narcotic
South Chungcheong Province said it was quickening its steps to construct a general hospital in Naepo New City in collaboration with Myongji Hospital.On Monday, South Chungcheong Province held the first meeting with Myongji Medical Foundation after signing a memorandum of understanding to construct a
Cancer patients are calling for insurance coverage of new anticancer drugs, such as AstraZeneca’s non-small cell lung cancer (NSCLC) treatment Tagrisso and Daiichi Sankyo’s metastatic breast cancer treatment Enhertu.Both drugs have confirmed their effectiveness but have failed to overcome the high h
Kisaco Research, a U.K. event organizer, announced that leading experts in microbiome drug development will gather in Seoul on May 17-18 at Microbiome Connect Asia to share the latest research and developments in the industry.Microbiome Connect is a global series of conferences dedicated to advancin
Celltrion Healthcare said it has recently hired Thomas Nusbickel, who has worked at multinational drugmakers such as Amgen and Pfizer, as Chief Commercial Officer (CCO) of Celltrion USA.According to Celltrion Healthcare, new CCO Nusbickel is an expert in sales, marketing, market access, and governme
With the patent of Amgen's denosumab (product name: Prolia and Xgeba) about to expire soon, companies in major markets have announced plans to release biosimilars, heralding another fierce market battle.Sandoz AG announced Monday that the U.S. FDA had accepted its biologics license application (BLA)
Cosmax, a Korean cosmetics manufacturer, said on Tuesday it developed a texture perception mechanism that can predict the usability of cosmetics without the need for applying it directly to the skin.A joint study led by Professor Park Jun-dong of Sookmyung Women's University investigated the relatio
Boryung posted all-time-high sales and operating profit in 2022 but it is expected to face risks over the domestic supply of Eli Lilly's diabetes treatment, rising marketing expenses, and investment in space business, an analyst said.According to provisional disclosure based on separate financial st
Two doctors are brought to court every day for professional negligence in Korea. The number is higher than that of cases doctors are charged with professional malpractice in the United Kingdom in a year.From 2013 to 2018, the number of cases in the U.K. where doctors were charged and convicted with